QuickView for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D6F2156FD0A5778107C1127A0843C523D%3Bjsessionid%3D06714C3F274B18A12D3ABD1AF87413C5%3Bjsessionid%3D8AB3FE4FB551010AE44D05D72DD0A1F4%3Bjsessionid%3D63E8D930E65F00703594CB8E4676F93D%3Bjsessionid%3D5FBFE683E989AFFC368CC233BFF22AC2%3Bjsessionid%3DF5BAA90526E406A8CCB0A71E52C9C5C2%3Bjsessionid%3D0814C1D804163417D75363E8C1665A1A%3Bjsessionid%3D93E48696CBCBF2BCBBE36B5C391EDF59%3Bjsessionid%3D38777750B9389867C6E44C23050AC179%3Bjsessionid%3D220D6A55C2DB17E219792313E9FAB98F%3Bjsessionid%3DF073E67D23AA973DA2BBDB53D18CE610%3Bjsessionid%3D323DC4FB66A55E329ECC4E49A866FD02%3Bjsessionid%3D7E9352C9197BF38F249309F563212DAD%3Bjsessionid%3D86123E7FDE6F71A786A53CE400E038CC%3Bjsessionid%3D5DA10E36FDA2CE83BE4381ABAB17E2C6%3Bjsessionid%3D4C8D9E851E2B88F0191D5646CFBF9B05%3Bjsessionid%3D3C82F21AE2A85ED8682A01E3CDFD95C6%3Bjsessionid%3DBF835F3DE23B935EB840E6B6D91CA4D0 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL%3Bjsessionid%3D40E22499564EAE7F71FA29AA19705F76%3Bjsessionid%3D787005E39F3AFF5E382EC41A340AB170%3Bjsessionid%3D31FD067A41084A84C97BE51309D7990D%3Bjsessionid%3D239C40B3727C3880B4DD59FDA993EB74%3Bjsessionid%3D12274BD3F00DF96945107322433EFB2D%3Bjsessionid%3DBABECBC0925C4C2EF20C533A8061A2D4%3Bjsessionid%3DA9E1B4939F78E3E99513BEFDCAAEE7BF%3Bjsessionid%3D0D3DBCFC8B84ADDE75E42324D8084A8D%3Bjsessionid%3D6F2156FD0A5778107C1127A0843C523D%3Bjsessionid%3D06714C3F274B18A12D3ABD1AF87413C5%3Bjsessionid%3D8AB3FE4FB551010AE44D05D72DD0A1F4%3Bjsessionid%3D63E8D930E65F00703594CB8E4676F93D%3Bjsessionid%3D5FBFE683E989AFFC368CC233BFF22AC2%3Bjsessionid%3DF5BAA90526E406A8CCB0A71E52C9C5C2%3Bjsessionid%3D0814C1D804163417D75363E8C1665A1A%3Bjsessionid%3D93E48696CBCBF2BCBBE36B5C391EDF59%3Bjsessionid%3D38777750B9389867C6E44C23050AC179%3Bjsessionid%3D220D6A55C2DB17E219792313E9FAB98F%3Bjsessionid%3DF073E67D23AA973DA2BBDB53D18CE610%3Bjsessionid%3D323DC4FB66A55E329ECC4E49A866FD02%3Bjsessionid%3D7E9352C9197BF38F249309F563212DAD%3Bjsessionid%3D86123E7FDE6F71A786A53CE400E038CC%3Bjsessionid%3D5DA10E36FDA2CE83BE4381ABAB17E2C6%3Bjsessionid%3D4C8D9E851E2B88F0191D5646CFBF9B05%3Bjsessionid%3D3C82F21AE2A85ED8682A01E3CDFD95C6%3Bjsessionid%3DBF835F3DE23B935EB840E6B6D91CA4D0